| ADR Ontology |
| ADR Term |
Intensive care unit acquired weakness |
| ADR ID |
BADD_A09347 |
| ADR Hierarchy |
|
| Description |
Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance. [MeSH] |
| MedDRA Code |
10077255 |
| MeSH ID |
D011115
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Critical illness polyneuropathy | Intensive care neuropathy | Critical illness myopathy | Intensive care unit acquired weakness | ICU acquired weakness | Polyneuropathies | Polyneuropathy | Polyneuropathy, Motor | Motor Polyneuropathies | Motor Polyneuropathy | Polyneuropathies, Motor | Polyneuropathy, Familial | Familial Polyneuropathies | Familial Polyneuropathy | Polyneuropathies, Familial | Polyneuropathy, Inherited | Inherited Polyneuropathies | Inherited Polyneuropathy | Polyneuropathies, Inherited | Polyneuropathy, Acquired | Acquired Polyneuropathies | Acquired Polyneuropathy | Polyneuropathies, Acquired | Polyneuropathy, Critical Illness | Critical Illness Polyneuropathies | Critical Illness Polyneuropathy | Polyneuropathies, Critical Illness |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00209 | Baclofen | 0.000176% | | | BADD_D01243 | Lamotrigine | 0.000258% | | | BADD_D02105 | Tacrolimus | 0.002129% | |
| The 1th Page 1
Total 1 Pages
|
|
